Farmak, one of Ukraine’s top pharmaceutical companies, has created a state-of-the-art PCR test to detect new variants of the novel coronavirus.
The joint commercial project with the Hromashevsky Institute of Epidemiology and Infectious Diseases allows scientists to carry out the sequencing procedure via reading the sequence of nucleotides in the RNA of the virus.
✅The results of the study, as well as information about the virus strains circulating in Ukraine since the beginning of the pandemic, have already been posted in the GISAID international initiative promoting the rapid sharing of data from all influenza viruses and the coronavirus causing COVID-19.
Farmak said that its product also detects the new UK variant of coronavirus. The PCR test system is based on the TaqPath COVID 19 RT PCR Kit (manufactured by Thermo Scientific, the United States), which is authorized by the U.S. Federal Drug Administration (FDA). High quality components made in the United States are used for the production of the new SARS-CoV-2 test kit.
The accuracy of the new test kit is verified by the findings of the Hromashevsky Institute of Epidemiology and Infectious Diseases of the Academy of Medical Sciences of Ukraine and the Mechnikov Institute of Microbiology and Immunology of the Academy of Medical Sciences of Ukraine in Kharkiv.
Reference trials of the PCR test kit are carried out in both private and public laboratories in Ukraine (Kharkiv, Dnipro, Zaporizhia, Vinnytsia), confirming its accuracy. Farmak says that the new test kit can be pre-oredered.
Via The UBN
Photo credit DW News